RUNX1 and neoplasm: The expression levels of particular MECOM isoforms propose that the N-terminal region of PRDM3 confers a tumor suppressor function, while the shorter EVI1 isoform is overexpressed in several malignancies and could have oncogenic properties in both myeloid and solid tumors [96,97,98].